Milestone Pharmaceuticals (MIST) Return on Capital Employed (2019 - 2022)
Milestone Pharmaceuticals (MIST) posted Return on Capital Employed of 76.85% for Q3 2022, down 53.25% on a QoQ basis from 50.15% in Q2 2022, and down 5075.0% year-over-year from 1.54% in Q3 2021.
Milestone Pharmaceuticals (MIST) Return on Capital Employed (2019 - 2022) Analysis & Trends
Milestone Pharmaceuticals' Return on Capital Employed history runs 4 years deep, the most recent figure standing at 76.85% for Q3 2022.
- Quarterly Return on Capital Employed fell 5075.0% year-over-year to 76.85% in Q3 2022, while the trailing twelve-month figure through Sep 2022 was 76.85% (down 5075.0% YoY) and the FY2021 annual result came in at 33.61%, up 523.0% from the prior year.
- Return on Capital Employed was 76.85% for Q3 2022 at Milestone Pharmaceuticals, down from 50.15% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 23.95% in Q2 2021 and bottomed at 76.85% in Q3 2022.
- A 4-year average of 45.39% and a median of 39.96% in 2019 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2021 — Return on Capital Employed surged 4241 bps — and 2022, when it sank 5075 bps.
- Milestone Pharmaceuticals' Return on Capital Employed stood at 46.55% in 2019, then rose by 12 bps to 41.15% in 2020, then increased by 13 bps to 35.88% in 2021, then tumbled by 114 bps to 76.85% in 2022.
- Business Quant data shows MIST's Return on Capital Employed at 76.85% in Q3 2022, 50.15% in Q2 2022, and 35.88% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -76.85% |
| Jun 30, 2022 | -50.15% |
| Dec 31, 2021 | -35.88% |
| Sep 30, 2021 | -26.10% |
| Jun 30, 2021 | -23.95% |
| Mar 31, 2021 | -33.63% |
| Dec 31, 2020 | -41.15% |
| Sep 30, 2020 | -63.98% |
| Jun 30, 2020 | -66.36% |
| Mar 31, 2020 | -58.49% |
| Dec 31, 2019 | -46.55% |
| Sep 30, 2019 | -35.57% |
| Jun 30, 2019 | -38.02% |
| Mar 31, 2019 | -38.76% |